Skip to main content
SpringerLink
Log in

Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kantarjian H, Talpaz M, O’Brien S, et al. High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome- positive chronic phase chronic myeloid leukemia. Blood. 2004;103:2873–2878.

    Article  PubMed  CAS  Google Scholar 

  2. O’Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronicphase chronic myeloid leukemia. N Engl J Med. 2003; 348: 994–1004.

    Article  PubMed  Google Scholar 

  3. Sumi M, Tauchi T, Sashida G, et al. Clinical usefulness of transcription-mediated amplification and hybridization protection assay in imatinib-treated chronic myelogenous leukemia patients. Clin Lab Haematol. 2005;27:416–417.

    Article  PubMed  CAS  Google Scholar 

  4. Higashi T, Tsukada J, Kato C, et al. Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: report of two cases. Am J Hematol. 2004;76:275–278.

    Article  PubMed  CAS  Google Scholar 

  5. Cortes J, O’Brien S, Kantarjian H. Discontinuation of imatinib therapy after achieving a molecular response. Blood. 2004; 104:2204–2205.

    Article  PubMed  CAS  Google Scholar 

  6. Mauro MJ, Druker BJ, Maziarz RT. Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission. Leuk Res. 2004;28(suppl 1):S71-S73.

    Article  PubMed  CAS  Google Scholar 

  7. Merante S, Orlandi E, Bernasconi P, Calatroni S, Boni M, Lazzarino M. Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation. Haematologica. 2005;90:979–981.

    PubMed  Google Scholar 

  8. Ghanima W, Kahrs J, Dahl TG 3rd,Tjonnfjord GE. Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia. Eur J Haematol. 2004;72:441–443.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, 160-0023, Tokyo, Japan

    Seiichi Okabe, Tetsuzo Tauchi, Yuko Ishii, Daigo Akahane, Kousuke Nunoda, Seiko Honda, Tomoiku Takaku & Kazuma Ohyashiki

Authors
  1. Seiichi Okabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuzo Tauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuko Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daigo Akahane
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kousuke Nunoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seiko Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tomoiku Takaku
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kazuma Ohyashiki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seiichi Okabe.

About this article

Cite this article

Okabe, S., Tauchi, T., Ishii, Y. et al. Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy. Int J Hematol 85, 173–174 (2007). https://doi.org/10.1532/IJH97.06187

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.06187

Keywords

Search

Navigation